bridging integrator 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of transcription by RNA polymerase II | ||
| endocytosis | ||
| nucleus organization | ||
| cytoskeleton organization | ||
| endosome to lysosome transport |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding | ||
| protein binding | ||
| phospholipid binding | ||
| lipid binding | ||
| aspartic-type endopeptidase inhibitor activity |
| Gene Ontology |
|---|
| phospholipid binding |
| InterPro |
|---|
| AH/BAR domain superfamily |
| Amphiphysin |
| BAR domain |
| SH3 domain |
| SH3-like domain superfamily |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111220 | centronuclear myopathy 2 | |
| DOID:2526 | prostate adenocarcinoma | |
| DOID:3459 | breast carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025